Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2020-01-09
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 32
- Registration Number
- NCT04221321
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Safety and Immunogenicity of CJ-40010 in Healthy Subjects
Phase 1
- Conditions
- Hand, Foot and Mouth Disease
- Interventions
- Biological: CJ-40010 EV71 vaccine A doseBiological: CJ-40010 CVA16 vaccine D doseBiological: CJ-40010 EV71 vaccine B doseBiological: CJ-40010 Bivalent vaccine E doseBiological: CJ-40010 CVA16 vaccine C doseBiological: CJ-40010 Bivalent vaccine high doseBiological: Placebo
- First Posted Date
- 2019-12-02
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT04182932
- Locations
- 🇰🇷
Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of
Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2020-05-08
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT04171687
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 102
- Registration Number
- NCT04128917
- Locations
- 🇰🇷
Chung-Ang University Hosptial, Seoul, Korea, Republic of
Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 32
- Registration Number
- NCT04066257
- Locations
- 🇰🇷
Chonbuk National University Hospital, Jeonju, Korea, Republic of
Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis
Phase 3
Completed
- Conditions
- Healed Erosive Esophagitis
- Interventions
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2023-01-27
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 351
- Registration Number
- NCT04022096
- Locations
- 🇰🇷
Hanyang University Seoul Hospital, Seoul, Korea, Republic of
Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male Subjects
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2019-08-22
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT03863938
- Locations
- 🇰🇷
Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Phase 4
Completed
- Conditions
- Hypertension, Hyperlipidemia
- Interventions
- Drug: Ezetimibe/Rosuvastatin
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 127
- Registration Number
- NCT03847506
- Locations
- 🇰🇷
Bundang Seoul National University Hospital, Gyeonggi-do, Seongnam-si, Bundang-gu, Korea, Republic of
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-01-24
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 25
- Registration Number
- NCT03814642
- Locations
- 🇰🇷
Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of
Bioequivalence Study of CJ-30060 in Healthy Volunteers
Phase 1
- Conditions
- Healthy Subjects
- Interventions
- Drug: CJ-30060 5/160/10mg
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2018-11-28
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 52
- Registration Number
- NCT03757390
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of